Y. Demchenko, O. Glebov, A. Zingone, J. Keats, P. Bergsagel et al., Classical and/or alternative NF{kappa}B pathway activation in multiple myeloma, Blood

S. Vallabhapurapu and K. M. , Regulation and Function of NF-??B Transcription Factors in the Immune System, Annual Review of Immunology, vol.27, issue.1, pp.693-733, 2009.
DOI : 10.1146/annurev.immunol.021908.132641

C. Annunziata, R. Davis, and Y. Demchenko, Frequent Engagement of the Classical and Alternative NF-??B Pathways by Diverse Genetic Abnormalities in Multiple Myeloma, Cancer Cell, vol.12, issue.2, pp.115-130, 2007.
DOI : 10.1016/j.ccr.2007.07.004

J. Keats, R. Fonseca, and M. Chesi, Promiscuous Mutations Activate the Noncanonical NF-??B Pathway in Multiple Myeloma, Cancer Cell, vol.12, issue.2, pp.131-144, 2007.
DOI : 10.1016/j.ccr.2007.07.003

D. Tarlinton, A. Radbruch, F. Hiepe, and T. Dörner, Plasma cell differentiation and survival. Current Opinion in Immunology Lymphocyte Development, Haruo Sugiyama, vol.20, pp.162-169, 2008.
DOI : 10.1016/j.coi.2008.03.016

O. Connor, B. Raman, V. Erickson, and L. , BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells, The Journal of Experimental Medicine, vol.157, issue.1, pp.91-98, 2004.
DOI : 10.1038/nsb769

J. Rossi, J. Moreaux, and D. Hose, Atacicept in relapsed/refractory multiple myeloma or active Waldenstr??m's macroglobulinemia: a phase I study, British Journal of Cancer, vol.106, issue.7, pp.1051-1058, 2009.
DOI : 10.1038/sj.leu.2405048

M. Jourdan, J. Moreaux, and J. Vos, B pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth, British Journal of Haematology, vol.83, issue.2, pp.160-168, 2007.
DOI : 10.1111/j.1365-2141.2007.06629.x
URL : https://hal.archives-ouvertes.fr/inserm-00160647

J. Moreaux, E. Legouffe, and E. Jourdan, BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone, Blood, vol.103, issue.8, pp.3148-3157, 2004.
DOI : 10.1182/blood-2003-06-1984
URL : https://hal.archives-ouvertes.fr/inserm-00129502

A. Sprynski, D. Hose, and L. Caillot, The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor, Blood, vol.113, issue.19, pp.4614-4626, 2009.
DOI : 10.1182/blood-2008-07-170464
URL : https://hal.archives-ouvertes.fr/inserm-00367812